SPY319.17+7.81 2.51%
DIA271.49+8.16 3.10%
IXIC9,804.32+188.51 1.96%

HC Wainwright & Co. Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $31

HC Wainwright & Co. maintains Aerie Pharmaceuticals (NASDAQ:AERI) with a Buy and lowers the price target from $37 to $31.

Benzinga · 05/07/2020 11:21

HC Wainwright & Co. maintains Aerie Pharmaceuticals (NASDAQ:AERI) with a Buy and lowers the price target from $37 to $31.